Progyny (PGNY) Short Interest Ratio & Short Volume $20.79 -0.19 (-0.91%) Closing price 04:00 PM EasternExtended Trading$20.68 -0.11 (-0.55%) As of 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Progyny Short Interest DataProgyny (PGNY) has a short interest of 6.91 million shares, representing 8.81% of the float (the number of shares available for trading by the public). This marks a 2.22% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.3, indicating that it would take 5.3 days of the average trading volume of 1.71 million shares to cover all short positions.Current Short Interest6,910,000 sharesPrevious Short Interest6,760,000 sharesChange Vs. Previous Month+2.22%Dollar Volume Sold Short$151.05 millionShort Interest Ratio5.3 Days to CoverLast Record DateMay 31, 2025Outstanding Shares85,718,000 sharesFloat Size78,450,000 sharesShort Percent of Float8.81%Today's Trading Volume1,111,853 sharesAverage Trading Volume1,705,150 sharesToday's Volume Vs. Average65% Short Selling Progyny? Sign up to receive the latest short interest report for Progyny and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPGNY Short Interest Over TimePGNY Days to Cover Over TimePGNY Percentage of Float Shorted Over Time Progyny Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20256,910,000 shares $151.05 million +2.2%8.8%5.3 $21.86 5/15/20256,760,000 shares $148.38 million -1.3%8.6%4.4 $21.95 4/30/20256,850,000 shares $156.45 million +5.2%9.6%4.3 $22.84 4/15/20256,510,000 shares $141.98 million +0.9%9.1%3.9 $21.81 3/31/20256,450,000 shares $144.09 million -36.6%9.0%3.5 $22.34 3/15/202510,170,000 shares $207.06 million -10.6%14.3%5.1 $20.36 2/28/202511,370,000 shares $256.17 million -2.4%15.9%6 $22.53 2/15/202511,650,000 shares $260.49 million +1.6%16.3%6.6 $22.36 1/31/202511,470,000 shares $265.76 million -0.5%16.1%6.2 $23.17 1/15/202511,530,000 shares $239.25 million -1.0%16.2%6.4 $20.75 Get the Latest News and Ratings for PGNY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Progyny and its competitors with MarketBeat's FREE daily newsletter. 12/31/202411,640,000 shares $200.79 million -4.6%16.4%6.6 $17.25 12/15/202412,200,000 shares $178.24 million +6.9%17.1%7.1 $14.61 11/30/202411,410,000 shares $177.65 million -0.1%15.8%5.1 $15.57 11/15/202411,420,000 shares $157.25 million +2.4%15.8%5 $13.77 10/31/202411,150,000 shares $167.81 million +11.8%14.6%5.2 $15.05 10/15/20249,970,000 shares $157.23 million +22.5%13.0%4.4 $15.77 9/30/20248,140,000 shares $136.43 million -11.0%10.6%3.8 $16.76 9/15/20249,150,000 shares $220.97 million +0.2%12.0%4.6 $24.15 8/31/20249,130,000 shares $214.46 million +10.4%11.9%6.9 $23.49 8/15/20248,270,000 shares $172.43 million +9.3%10.7%6.6 $20.85 7/31/20247,570,000 shares $213.47 million -3.7%9.8%5.6 $28.20 7/15/20247,860,000 shares $228.18 million +3.8%9.6%6.8 $29.03 6/30/20247,570,000 shares $216.58 million +0.4%9.3%6.7 $28.61 6/15/20247,540,000 shares $203.43 million +2.6%9.2%7 $26.98 5/31/20247,350,000 shares $198.08 million -3.5%9.0%7.1 $26.95 5/15/20247,620,000 shares $204.06 million +6.6%9.3%6.9 $26.78 4/30/20247,150,000 shares $229.23 million +8.3%8.6%8.1 $32.06 4/15/20246,600,000 shares $223.15 million +1.1%8.0%8 $33.81 3/31/20246,530,000 shares $249.12 million +5.3%7.9%8.1 $38.15 3/15/20246,200,000 shares $218.05 million -4.3%7.5%7.9 $35.17 2/29/20246,480,000 shares $236.65 million -1.1%7.8%8 $36.52 2/15/20246,550,000 shares $271.04 million +5.3%7.9%9.4 $41.38 1/31/20246,220,000 shares $236.92 million +18.5%7.5%8.6 $38.09 1/15/20245,250,000 shares $204.70 million -4.4%6.4%7 $38.99 12/31/20235,490,000 shares $204.12 million -15.5%6.6%7.2 $37.18 12/15/20236,500,000 shares $224.25 million +17.5%7.9%8.4 $34.50 11/30/20235,530,000 shares $190.01 million -2.5%6.7%7.2 $34.36 11/15/20235,670,000 shares $184.96 million +8.2%6.9%7.6 $32.62 10/31/20235,240,000 shares $161.71 million +1.2%6.4%7.1 $30.86 10/15/20235,180,000 shares $171.51 million -7.7%6.3%7.4 $33.11New Rule Hits in July — The Smart Money Already Moved (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how 9/30/20235,610,000 shares $190.85 million +2.9%6.8%8.2 $34.02 9/15/20235,450,000 shares $186.44 million +0.7%6.6%8 $34.21 8/31/20235,410,000 shares $202.01 million -4.9%6.6%8 $37.34 8/15/20235,690,000 shares $220.89 million -0.5%6.9%8.3 $38.82 7/31/20235,720,000 shares $238.87 million -5.3%7.3%7.6 $41.76 7/15/20236,040,000 shares $234.35 million -1.5%7.8%8.3 $38.80 6/30/20236,130,000 shares $241.15 million -0.7%7.9%8 $39.34 6/15/20236,170,000 shares $246.86 million +0.7%8.0%7.8 $40.01 5/31/20236,130,000 shares $228.34 million +2.5%8.1%7.5 $37.25 5/15/20235,980,000 shares $215.22 million -7.7%7.9%6.2 $35.99 4/30/20236,480,000 shares $215.40 million -1.4%8.6%6.6 $33.24 4/15/20236,570,000 shares $212.80 million +2.8%8.8%6.8 $32.39 3/31/20236,390,000 shares $205.25 million -3.2%8.5%6.6 $32.12 3/15/20236,600,000 shares $223.48 million +11.3%8.8%7 $33.86 2/28/20235,930,000 shares $222.73 million -7.9%7.9%5.9 $37.56 2/15/20236,440,000 shares $218.90 million -1.2%8.6%7.2 $33.99 1/31/20236,520,000 shares $224.22 million -3.6%8.8%7.3 $34.39 1/15/20236,760,000 shares $224.97 million -9.6%9.1%8 $33.28 12/30/20227,480,000 shares $233.00 million -5.9%9.2%8.9 $31.15 12/15/20227,950,000 shares $243.03 million +9.7%9.8%9.8 $30.57 11/30/20227,250,000 shares $265.57 million +2.1%9.0%9.5 $36.63 11/15/20227,100,000 shares $265.61 million +18.9%8.8%11.2 $37.41 10/31/20225,970,000 shares $265.49 million +7.0%7.4%9.5 $44.47 10/15/20225,580,000 shares $206.57 million +10.3%7.7%8.4 $37.02 9/30/20225,060,000 shares $187.52 million +12.7%7.0%7.4 $37.06 9/15/20224,490,000 shares $190.02 million -4.1%6.2%6 $42.32 8/31/20224,680,000 shares $188.18 million -7.3%6.4%6 $40.21 8/15/20225,050,000 shares $232.70 million -16.3%6.9%5.7 $46.08 7/31/20226,030,000 shares $184.10 million -5.0%8.2%6.8 $30.53 7/15/20226,350,000 shares $194.37 million -4.5%9.0%8.2 $30.61 6/30/20226,650,000 shares $193.18 million +11.4%9.4%8.9 $29.05 6/15/20225,970,000 shares $162.92 million +3.3%8.5%8.2 $27.29 5/31/20225,780,000 shares $182.71 million -2.7%8.2%8.7 $31.61 5/15/20225,940,000 shares $0.00 +6.3%8.4%9.1 $0.00 4/30/20225,590,000 shares $214.94 million +9.0%8.0%8.6 $38.45 4/15/20225,130,000 shares $215.20 million -3.0%7.4%7.5 $41.95 3/31/20225,290,000 shares $271.91 million -6.5%7.6%7 $51.40 3/15/20225,660,000 shares $237.49 million -4.1%8.2%7.4 $41.96 2/28/20225,900,000 shares $232.22 million -2.3%8.5%7.4 $39.36 2/15/20226,040,000 shares $249.33 million +3.1%8.8%7.9 $41.28 1/31/20225,860,000 shares $237.33 million +5.8%8.8%7.5 $40.50 1/15/20225,540,000 shares $239.27 million +3.8%8.3%7 $43.19 12/31/20215,340,000 shares $268.87 million +14.8%8.0%7.5 $50.35 12/15/20214,650,000 shares $229.29 million -1.3%6.9%6.5 $49.31 11/30/20214,710,000 shares $239.13 million +0.6%7.0%5.5 $50.77 11/15/20214,680,000 shares $292.31 million -11.9%7.0%5.4 $62.46 10/29/20215,310,000 shares $326.19 million +0.6%8.1%6 $61.43 10/15/20215,280,000 shares $295.63 million +4.6%8.1%6 $55.99 9/30/20215,050,000 shares $282.80 million +20.2%7.8%5.4 $56.00 9/15/20214,200,000 shares $254.60 million -0.5%6.5%4 $60.62Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. For the moment, you can watch this interview free of charge – just click here. 8/31/20214,220,000 shares $235.77 million +25.2%6.5%4.1 $55.87 8/13/20213,370,000 shares $155.46 million -10.6%6.2%3.2 $46.13 7/30/20213,770,000 shares $209.95 million -6.0%7.0%3.6 $55.69 7/15/20214,010,000 shares $221.23 million +0.5%7.3%3.9 $55.17 6/30/20213,990,000 shares $235.41 million +47.8%7.2%3.4 $59.00 6/15/20212,700,000 shares $172.31 million +19.5%5.5%2.6 $63.82 5/28/20212,260,000 shares $144.73 million -5.8%4.6%2.4 $64.04 5/14/20212,400,000 shares $115.42 million -14.6%5.3%2.5 $48.09 4/30/20212,810,000 shares $164.33 million +27.2%6.3%3.1 $58.48 4/15/20212,210,000 shares $110.17 million -5.2%5.2%2.4 $49.85 3/31/20212,330,000 shares $100.98 million +7.4%5.4%3.1 $43.34 3/15/20212,170,000 shares $105.44 million +6.4%5.0%2.9 $48.59 2/26/20212,040,000 shares $88.35 million -8.5%4.8%2.4 $43.31 2/12/20212,230,000 shares $111.25 million -0.9%5.2%2.7 $49.89 1/29/20212,250,000 shares $104.67 million -11.4%5.0%2.6 $46.52 1/15/20212,540,000 shares $114.17 million +1.6%5.7%3 $44.95 12/31/20202,500,000 shares $107.75 million -14.4%5.8%3.1 $43.10 12/15/20202,920,000 shares $118.46 million -12.6%7.0%3.7 $40.57 11/30/20203,340,000 shares $120.17 million +28.0%8.1%4.4 $35.98 11/15/20202,610,000 shares $80.13 million -20.7%6.9%3.6 $30.70 10/30/20203,290,000 shares $80.93 million -3.5%9.2%4.6 $24.60 10/15/20203,410,000 shares $98.04 million -7.6%9.6%4.5 $28.75 9/30/20203,690,000 shares $108.60 million +12.2%10.6%4.7 $29.43 9/15/20203,290,000 shares $90.05 million +5.5%9.7%3.9 $27.37 8/31/20203,120,000 shares $89.08 million -2.5%9.3%3.6 $28.55 8/14/20203,200,000 shares $94.91 million -3.0%10.6%3.6 $29.66 7/31/20203,300,000 shares $87.88 million -2.4%11.1%3.3 $26.63 7/15/20203,380,000 shares $83.72 million -4.5%11.6%3.7 $24.77 6/30/20203,540,000 shares $91.37 million +23.8%12.4%3.9 $25.81 PGNY Short Interest - Frequently Asked Questions What is Progyny's current short interest? Short interest is the volume of Progyny shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 6,910,000 shares of PGNY short. 8.81% of Progyny's shares are currently sold short. Learn More on Progyny's current short interest. What is a good short interest ratio for Progyny? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PGNY shares currently have a short interest ratio of 5.0. Learn More on Progyny's short interest ratio. What is a good short interest percentage for Progyny? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.81% of Progyny's floating shares are currently sold short. Is Progyny's short interest increasing or decreasing? Progyny saw a increase in short interest during the month of May. As of May 31st, there was short interest totaling 6,910,000 shares, an increase of 2.2% from the previous total of 6,760,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Progyny's float size? Progyny currently has issued a total of 85,718,000 shares. Some of Progyny's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Progyny currently has a public float of 78,450,000 shares. How does Progyny's short interest compare to its competitors? 8.81% of Progyny's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Progyny: Guardant Health, Inc. (7.60%), Option Care Health, Inc. (3.57%), RadNet, Inc. (9.62%), BrightSpring Health Services, Inc. (14.46%), Sotera Health (8.50%), Surgery Partners, Inc. (12.33%), Privia Health Group, Inc. (3.18%), Addus HomeCare Co. (4.84%), Veracyte, Inc. (7.15%), LifeStance Health Group, Inc. (7.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Progyny stock? Short selling PGNY is an investing strategy that aims to generate trading profit from Progyny as its price is falling. PGNY shares are trading down $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Progyny? A short squeeze for Progyny occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PGNY, which in turn drives the price of the stock up even further. How often is Progyny's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PGNY, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies GH Short Interest Data OPCH Short Interest Data RDNT Short Interest Data BTSG Short Interest Data SHC Short Interest Data SGRY Short Interest Data PRVA Short Interest Data ADUS Short Interest Data VCYT Short Interest Data LFST Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PGNY) was last updated on 6/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Progyny, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Progyny With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
